Stockreport

Acceleron Reports Third Quarter 2019 Operating and Financial Results

Acceleron Pharma Inc.  (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations
PDF - FDA’s review of luspatercept BLA for the beta-thalassemia and lower-risk MDS indications remains ongoing -- Six clinical abstracts accepted for presentation at the 61s [Read more]